Susan Cornell
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Periodontics top 10%
Papers in
-
- Diabetes Treatment and Management 15
- Diabetes Management and Research 8
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 2
- Surgery 4
- Co-authors
- Mark H. Perrone (2 shared papers)Dilip Amin (2 shared papers)Glenda E. Bilder (1 shared paper)Curtis Triplitt (1 shared paper)Jørgen Slots (1 shared paper)Joseph M. DiRienzo (1 shared paper)Lon J. Van Winkle (2 shared papers)Jacalyn M. Green (2 shared papers)
- Journals
- American Journal of Pharmaceutical Education (2 papers)Journal of the American Pharmacists Association (2 papers)Health Policy (1 paper)Therapeutics and Clinical Risk Management (1 paper)Pharmacology (1 paper)
- Partner nations
- United StatesItalyIreland
In The Last Decade
Susan Cornell
24 papers receiving 444 citations
Peers
Comparison fields: 5 of 89
- Endocrinology, Diabetes and Metabolism 182
- Periodontics 24
- Geriatrics and Gerontology 9
- Orthopedics and Sports Medicine 20
- Pharmacology 36
Countries citing papers authored by Susan Cornell
This map shows the geographic impact of Susan Cornell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Cornell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Cornell more than expected).
Fields of papers citing papers by Susan Cornell
This network shows the impact of papers produced by Susan Cornell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Cornell. The network helps show where Susan Cornell may publish in the future.
Co-authors
The 25 scholars most cited alongside Susan Cornell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 105 | |
| 2 | 1-Hydroxy-3-(methylpentylamino)-propylidene-1,1-bisphosphonic acid as a potent inhibitor of squalene synthase. | 1996 | 50 |
| 3 | 2012 | 39 | |
| 4 | 2015 | 36 | |
| 5 | 2012 | 33 | |
| 6 | 2013 | 32 | |
| 7 | 1990 | 30 | |
| 8 | 2017 | 30 | |
| 9 | 2015 | 23 | |
| 10 | 2004 | 17 | |
| 11 | 2012 | 14 | |
| 12 | 2008 | 10 | |
| 13 | 2004 | 9 | |
| 14 | 2011 | 6 | |
| 15 | 2014 | 6 | |
| 16 | 2010 | 5 | |
| 17 | 2014 | 4 | |
| 18 | 2013 | 4 | |
| 19 | 2006 | 2 | |
| 20 | 2022 | 2 |
About Susan Cornell
Susan Cornell is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Pharmacology and General Health Professions, having authored 25 papers that have together received 461 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (15 papers), Diabetes Management and Research (8 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers), Plant biochemistry and biosynthesis (2 papers), Peptidase Inhibition and Analysis (2 papers), Pharmacology and Obesity Treatment (2 papers), Metabolism, Diabetes, and Cancer (2 papers) and Computational Drug Discovery Methods (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (182 citations), Periodontics (24 citations), Geriatrics and Gerontology (9 citations), Orthopedics and Sports Medicine (20 citations) and Pharmacology (36 citations). Susan Cornell has collaborated with scholars based in United States, Italy and Ireland. Frequent co-authors include Mark H. Perrone, Dilip Amin, Glenda E. Bilder, Curtis Triplitt, Jørgen Slots, Joseph M. DiRienzo, Lon J. Van Winkle, Jacalyn M. Green, Nancy Fjortoft and Sophie La Salle. Their work appears in journals such as American Journal of Pharmaceutical Education, Journal of the American Pharmacists Association, Health Policy, Therapeutics and Clinical Risk Management and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.